A global overview of the impact of peritoneal dialysis first or favored policies: An opinion

Peritoneal Dialysis International

Volumn 35, Issue 4, 2015, Pages 406-420

  Liu, Frank Xiaoqing ^a   Gao, Xin ^b   Inglese, Gary ^c   Chuengsaman, Piyatida ^d   Pecoits Filho, Roberto ^e   Yu, Alex ^f  

^a BAXTER HEALTHCARE CORPORATION   (United States)

^b PHARMERIT INTERNATIONAL   (United States)

^c HOLLISTER INCORPORATED   (United States)

^d Ban Phaeo Hospital   (Thailand)

^e PONTIFICAL CATHOLIC UNIVERSITY OF PARANÁ   (Brazil)

^f Hong Kong Baptist Hospital   (China)

Author keywords

Global overview; Peritoneal dialysis; Peritoneal dialysis favored policy; Peritoneal dialysis first policy

Indexed keywords

ARTICLE; CHRONIC KIDNEY DISEASE; DOCTORAL EDUCATION; END STAGE RENAL DISEASE; GOVERNMENT; HEALTH CARE COST; HEMODIALYSIS; HOME DIALYSIS; HUMAN; PATIENT COMFORT; PATIENT EDUCATION; PERITONEAL DIALYSIS; PERITONITIS; POLICY; PRIORITY JOURNAL; RENAL REPLACEMENT THERAPY; TREATMENT OUTCOME; AGED; ECONOMICS; FEMALE; HEALTH; HEALTH CARE POLICY; KIDNEY FAILURE, CHRONIC; MALE; MANAGEMENT; MORTALITY; PRACTICE GUIDELINE; PROCEDURES; STATISTICS AND NUMERICAL DATA; VERY ELDERLY;

AGED; AGED, 80 AND OVER; FEMALE; GLOBAL HEALTH; HEALTH POLICY; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; PERITONEAL DIALYSIS; POLICY MAKING; PRACTICE GUIDELINES AS TOPIC; TREATMENT OUTCOME;

EID: 84938272274     PISSN: 08968608     EISSN: 17184304     Source Type: Journal    
DOI: 10.3747/pdi.2013.00204     Document Type: Article

References (128)

1. Nugent RA, Fathima SF, Feigl AB, Chyung D. The burden of chronic kidney disease on developing nations: a 21st century challenge in global health. Nephron Clin Pract 2011; 118(3):c269–77.
2. Ayodele OE, Alebiosu CO. Burden of chronic kidney disease: an international perspective. Adv Chronic Kidney Dis 2010; 17(3):215–24.
3. Khawar O, Kalantar-Zadeh K, Lo WK, Johnson D, Mehrotra R. Is the declining use of long-term peritoneal dialysis justified by outcome data? Clin J Am Soc Nephrol 2007; 2(6):1317–28.
4. Heaf JG, Lokkegaard H, Madsen M. Initial survival advantage of peritoneal dialysis relative to haemodialysis. Nephrol Dial Transplant 2002; 17(1):112–7.
5. Liem YS, Wong JB, Hunink MG, de Charro FT, Winkelmayer WC. Comparison of hemodialysis and peritoneal dialysis survival in the Netherlands. Kidney Int 2007; 71(2):153–8.
6. McDonald SP, Marshall MR, Johnson DW, Polkinghorne KR. Relationship between dialysis modality and mortality. JAm Soc Nephrol 2009; 20(1):155–63.
7. Chiu Y-W, Jiwakanon S, Lukowsky L, Duong U, Kalantar-Zadeh K, Mehrotra R. An update on the comparisons of mortality outcomes of hemodialysis and peritoneal dialysis patients. Semin Nephrol 2011; 31(2):152-8.
8. Davies SJ. Peritoneal dialysis—current status and future challenges. Nat Rev Nephrol 2013; 9(7):399–408.
9. Yeates K, Zhu N, Vonesh E, Trpeski L, Blake P, Fenton S. Hemodialysis and peritoneal dialysis are associated with similar outcomes for end-stage renal disease treatment in Canada. Nephrol Dial Transplant 2012; 27(9):3568–75.
10. Lee CC, Sun CY, Wu MS. Long-term modality-related mortality analysis in incident dialysis patients. Perit Dial Int 2009; 29(2):182–90.
11. Huang CC, Cheng KF, Wu HD. Survival analysis: comparing peritoneal dialysis and hemodialysis in Taiwan. Perit Dial Int 2008; 28(Suppl 3):S15–20.
12. Sanabria M, Munoz J, Trillos C, Hernandez D, Latorre C, Diaz CS, et al. Dialysis outcomes in Colombia (DOC) study: a comparison of patient survival on peritoneal dialysis vs hemodialysis in Colombia. Kidney Int 2008; 73(Suppl 108):S165–72.
13. Weinhandl ED, Foley RN, Gilbertson DT, Arneson TJ, Snyder JJ, Collins AJ. Propensity-matched mortality comparison of incident hemodialysis and peritoneal dialysis patients. J Am Soc Nephrol 2010; 21(3):499–506.
14. Mehrotra R, Chiu YW, Kalantar-Zadeh K, Bargman J, Vonesh E. Similar outcomes with hemodialysis and peritoneal dialysis in patients with end-stage renal disease. Arch Intern Med 2011; 171(2):110–8.
15. Brown EA, Johansson L, Farrington K, Gallagher H, Sensky T, Gordon F, et al. Broadening Options for Long-term Dialysis in the Elderly (BOLDE): differences in quality of life on peritoneal dialysis compared to haemodialysis for older patients. Nephrol Dial Transplant 2010; 25(11):3755–63.
16. Rubin HR, Fink NE, Plantinga LC, Sadler JH, Kliger AS, Powe NR. Patient ratings of dialysis care with peritoneal dialysis vs hemodialysis. JAMA 2004; 291(6):697–703.
17. Bohlke M, Nunes DL, Marini SS, Kitamura C, Andrade M, Von-Gysel MP. Predictors of quality of life among patients on dialysis in southern Brazil. Sao Paulo Med J 2008; 126(5):252–6.
18. Goodlad C, Brown E. The role of peritoneal dialysis in modern renal replacement therapy. Postgraduate Med J 2013; 89(1056):584–90.
19. Juergensen E, Wuerth D, Finkelstein SH, Juergensen PH, Bekui A, Finkelstein FO. Hemodialysis and peritoneal dialysis: patients’ assessment of their satisfaction with therapy and the impact of the therapy on their lives. Clin J Am Soc Nephrol 2006; 1(6):1191–6.
20. McLaughlin K, Manns B, Mortis G, Hons R, Taub K. Why patients with ESRD do not select self-care dialysis as a treatment option. Am J Kidney Dis 2003; 41(2):380–5.
21. Liem YS, Bosch JL, Arends LR, Heijenbrok-Kal MH, Hunink MG. Quality of life assessed with the Medical Outcomes Study Short Form 36-Item Health Survey of patients on renal replacement therapy: a systematic review and meta-analysis. Value Health 2007; 10(5):390–7.
22. Wyld M, Morton RL, Hayen A, Howard K, Webster AC. A systematic review and meta-analysis of utility-based quality of life in chronic kidney disease treatments. PLoS Med 2012; 9(9):e1001307.
23. Frimat L, Durand PY, Loos-Ayav C, Villar E, Panescu V, Briancon S, et al. Impact of first dialysis modality on outcome of patients contraindicated for kidney transplant. Perit Dial Int 2006; 26(2):231–9.
24. Just PM, Riella MC, Tschosik EA, Noe LL, Bhattacharyya SK, de Charro F. Economic evaluations of dialysis treatment modalities. Health Policy 2008; 86(2 3):163–80.
25. Liu FX, Quock TP, John B, Noe L, Inglese G. Economic evaluations of peritoneal dialysis and hemodialysis: 2004–2012. F1000Research 2013; 2-273:1–10.
26. Klarenbach S, Manns B. Economic evaluation of dialysis therapies. Semin Nephrol 2009; 29(5):524–32.
27. United States, Department of Health and Human Services, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, US Renal Data System (USRDS). USRDS 2012 Annual data report: Atlas of chronic kidney disease and end-stage renal disease in the United States. Bethesda, MD, USRDS; 2012. Available from: http://www.usrds.org/adr.aspx.
28. Ledebo I, Ronco C. The best dialysis therapy? Results from an international survey among nephrology professionals. NDT Plus 2008; 1(6):403–8.
29. Morton RL, Tong A, Howard K, Snelling P, Webster AC. The views of patients and carers in treatment decision making for chronic kidney disease: systematic review and thematic synthesis of qualitative studies. Brit Med J (Clinical research ed) 2010; 340:c112.
30. Morton RL, Snelling P, Webster AC, Rose J, Masterson R, Johnson DW, et al. Dialysis modality preference of patients with CKD and family caregivers: a discrete-choice study. Am J Kidney Dis 2012; 60(1):102–11.
31. Jager KJ, Korevaar JC, Dekker FW, Krediet RT, Boeschoten EW. The effect of contraindications and patient preference on dialysis modality selection in ESRD patients in the Netherlands. Am J Kidney Dis 2004; 43(5):891–9.
32. Jiwakanon S, Chiu YW, Kalantar-Zadeh K, Mehrotra R. Peritoneal dialysis: an underutilized modality. Curr Opin Nephrol Hy 2010; 19(6):573–7.
33. Koc Y, Unsal A, Basturk T, Sakaci T, Ahbap-Dal E, Sinangil-Arar A, et al. Is there impact of mortality prior hemodialysis therapy in peritoneal dialysis patients? Nefrologia 2012; 32(3):335–42.
34. Chui BK, Manns B, Pannu N, Dong J, Wiebe N, Jindal K, et al. Health care costs of peritoneal dialysis technique failure and dialysis modality switching. Am J Kidney Dis 2013; 61(1):104–11.
35. Couser WG, Remuzzi G, Mendis S, Tonelli M. The contribution of chronic kidney disease to the global burden of major noncommunicable diseases. Kidney Int 2011; 80(12):1258–70.
36. Yu AW, Chau KF, Ho YW, Li PK. Development of the “peritoneal dialysis first” model in Hong Kong. Perit Dial Int 2007; 27(Suppl 2):S53–5.
37. Sirivongs D, Kasemup V, Wangsiripaisal A, Jamma J. Facts about PD first policy in Thailand. National Health Security Office of Thailand. Nonthaburi, Thailand: Sahamitrprinting and Publishing Company, Ltd.; 2011
38. Oreopoulos DG, Coleman S, Doyle E. Reversing the decreasing peritoneal dialysis (PD) trend in Ontario: a government initiative to increase PD use in Ontario to 30% by 2010. Perit Dial Int 2007; 27(5):489–95.
39. Iglehart JK. Bundled Payment for ESRD—Including ESAs in Medicare’s dialysis package. New Engl J Med 2011; 364(7):593–5.
40. Golper TA, Guest S, Glickman JD, Turk J, Pulliam JP. Home dialysis in the new USA Bundled Payment Plan: implications and impact. Perit Dial Int 2011; 31(1):12–6.
41. Li PK, Szeto CC. Success of the peritoneal dialysis programme in Hong Kong. Nephrol Dial Transplant 2008; 23(5):1475–8.
42. Ho YW, Chau KF, Choy BY, Fung KS, Cheng YL, Kwan TH, et al. Hong Kong Renal Registry Report 2010. Hong Kong J Nephrology. 2010; 12(2):81–98.
43. Dhanakijcharoen P, Sirivongs D, Aruyapitipan S, Chuengsaman P, Lumpaopong A. The “PD First” policy in Thailand: three-years experiences (2008–2011). J Med Assoc Thai 2011; 94(Suppl 4):S153–61.
44. Quinn RR, Laupacis A, Hux JE, Moineddin R, Paterson M, Oliver MJ. Forecasting the need for dialysis services in Ontario, Canada to 2011. Healthc Policy 2009; 4(4):e151–61.
45. Canadian Institute for Health Information. Canadian Organ Replacement Register Annual Report: Treatment of End-Stage Organ Failure in Canada, 2001 to 2010 Ottawa, Ontario: Canadian Institute for Health Information; 2010. Available from: https://secure.cihi.ca/free_products/2011_CORR_Annua_Report_EN.pdf.
46. Maddux FW. Impact of the bundled end-stage renal disease payment system on patient care. Blood purif 2012; 33(1 3):107–11.
47. Hornberger J, Hirth RA. Financial implications of choice of dialysis type of the revised Medicare payment system: an economic analysis. Am J Kidney Dis 2012; 60(2):280–7.
48. Hirth RA, Turenne MN, Wheeler JR, Nahra TA, Sleeman KK,Zhang W, et al. The initial impact of Medicare’s new prospective payment system for kidney dialysis. Am J Kidney Dis 2013; 62(4):662–9.
49. Li PK, Chow KM. The cost barrier to peritoneal dialysis in the developing world—an Asian perspective. Perit Dial Int 2001; 21(Suppl 3):S307–13.
50. Lo WK. Peritoneal dialysis in the far East—an astonishing situation in 2008. Perit Dial Int 2009; 29(Suppl 2):S227–9.
51. Tantivess S, Werayingyong P, Chuengsaman P, Teerawattananon Y. Universal coverage of renal dialysis in Thailand: promise, progress, and prospects. Brit Med J (Clinical research ed) 2013; 346.
52. Manns BJ, Mendelssohn DC, Taub KJ. The economics of end-stage renal disease care in Canada: incentives and impact on delivery of care. Int J Health Care Finance Econ 2007; 7(2 3):149–69.
53. Blake PG, Bargman JM, Brimble KS, Davison SN, Hirsch D, McCormick BB, et al. Clinical practice guidelines and recommendations on peritoneal dialysis adequacy. Perit Dial Int 2011; 31(2):218–39.
54. Provincial Peritoneal Dialysis Coordinating Committee. Provincial peritoneal dialysis joint initiative, strategy on increasing peritoneal dialysis (PD) use in Ontario 2006 [updated 2006; cited 2013 July 15]. Available from: http://orp.renalnetwork.on.ca/common/pages/UserFile.aspx?fileId=100547.
55. Ontario Renal Network. Ontario Renal Network Plan 2012–2015: Ontario Renal Network; 2012 [updated 2012; cited 2012 August 29]. Available from: http://orp.renalnetwork.on.ca/.
56. Blake PG. Peritoneal dialysis in North America: 2013 update. [PowerPoint Presentation]. In press 2013.
57. Thaizhou Human Resources and Social Scurity Bureau. Notice on strengthening the management of medical insurance peritoneal dialysis Thaizhou City, China 2012 [updated 2012; cited 2012 September 21]. Available from: http://www.jstz.lss.gov.cn.
58. Kidney Care Network. The peritoneal dialysate home delivery policy recently introduced in Wuxi, China 2012 [updated 2012; cited 2012 September 12]. Available from: www.shentouxi.com.cn.
59. ChinaBio Today. Baxter Teams with China Officials to Bring Dialysis to Rural China. China Bio Today [Internet]. 2013 September 7. Available from: http://www.chinabiotoday.com/articles/20130403.
60. The Central People’s Government of the People’s Rebulic of China. Peritoneal dialysis policy in China – the Office of the Ministry of Health 2012 [updated 2012; cited 2012 March 26]. Available from: http://www.gov.cn/gzdt/2011-06/13/content_1882823.htm.
61. Guatemala Public Health and Social Security. Unidad Nacional de Atención al Enfermo Renal Crónico 2012 [updated 2012; cited 2012 May 14]. Available from: http://unaerc.gob.gt/.
62. Jain AK, Blake P, Cordy P, Garg AX. Global trends in rates of peritoneal dialysis. J Am Soc Nephrol 2012; 23(3):533–44.
63. Abraham G, Pratap B, Sankarasubbaiyan S, Govindan P, Nayak KS, Sheriff R, et al. Chronic peritoneal dialysis in South Asia—challenges and future. Perit Dial Int 2008; 28(1):13–9.
64. Agarwal SK, Srivastava RK. Chronic kidney disease in India: challenges and solutions. Nephron Clin Pract 2009; 111(3):c197–203.
65. Jeloka TK, Upase S, Chitikeshi S. Monthly cost of three exchanges a day peritoneal dialysis is same as of thrice a week hemodialysis in self-paying Indian patients. Indian J Nephrol 2012; 22(1):39–41.
66. Reddy YNV, Abraham G, Mathew M, Ravichandran R, Reddy YNV. An Indian model for cost-effective CAPD with minimal man power and economic resources. Nephrol Dial Transplant 2011 Oct; 26(10):3089–91.
67. Rajendran S. Good news for kidney patients, pilot project on peritoneal dialysis in Bangalore: The Hindu; 2013 [cited 2013 December 30]. Available from: http://www.thehindu.com/news/national/karnataka/good-news-for-kidney-patients-pilot-project-on-peritoneal-dialysis-in-bangalore/article5258226.ece.
68. Jha V. Current status of end-stage renal disease care in South Asia. Ethn Dis 2009; 19(Suppl 1):S1–27–32.
69. Cueto-Manzano AM, Rojas-Campos E. Status of renal replacement therapy and peritoneal dialysis in Mexico. Perit Dial Int 2007; 27(2):142–8.
70. National Institute of Statistics and Geography. National Information by State and Municipalities 2013 [cited 2013 July 16]. Available from: http://www3.inegi.org.mx/sistemas/mexicocifras.
71. Paniagua R, Ramos A, Fabian R, Lagunas J, Amato D. Chronic kidney disease and dialysis in Mexico. Perit Dial Int 2007; 27(4):405–9.
72. Trevino-Becerra A. The mexican peritoneal dialysis model: a personal reflection. Artif Organs 2007; 31(4):249–52.
73. Registro Español de Enfermos Renales. Dialysis and transplant report in Spain, 2006. Nefrologia 2009; 29(6):525–33.
74. Arrieta J, Bajo MA, Caravaca F, Coronel F, Garcia-Perez H, Gonzalez-Parra E, et al. Guidelines of the Spanish Society of Nephrology. Clinical practice guidelines for peritoneal dialysis. Nefrologia 2006; 26(Suppl 4):1–184.
75. Quiros-Ganga PL, Remon-Rodriguez C. Achieving better results for peritoneal dialysis in recent years. Nefrologia 2012; 32(5):587–96.
76. Villa G, Rodriguez-Carmona A, Fernandez-Ortiz L, Cuervo J, Rebollo P, Otero A, et al. Cost analysis of the Spanish renal replacement therapy programme. Nephrol Dial Transplant 2011; 26(11):3709–14.
77. Chen TW, Li SY, Chen JY, Yang WC. Training of peritoneal dialysis patients—Taiwan’s experiences. Perit Dial Int 2008; 28(Suppl 3):S72–5.
78. Kao TW, Chang YY, Chen PC, Hsu CC, Chang YK, Chang YH, et al. Lifetime costs for peritoneal dialysis and hemodialysis in patients in Taiwan. Perit Dial Int 2013; 33(6):671-8.
79. Peng YS, Chiang CK, Hung KY, Chang CH, Lin CY, Yang CS, et al. Comparison of self-reported health-related quality of life between Taiwan hemodialysis and peritoneal dialysis patients: a multi-center collaborative study. Qual Life Res 2011; 20(3):399–405.
80. Wu IW, Wang SY, Hsu KH, Lee CC, Sun CY, Tsai CJ, et al. Multidisciplinary predialysis education decreases the incidence of dialysis and reduces mortality—a controlled cohort study based on the NKF/DOQI guidelines. Nephrol Dial Transplant 2009; 24(11):3426–33.
81. Queensland Government. Queensland Statewide Renal Health Services Plan, 2008–17, Part 2 2008 [updated 2008; cited 2003 July 16]. Available from: http://pandora.nla.gov.au/pan/108521/20091015-1137/www.health.qld.gov.au/publications/qh_plans/QS_renal_plan_part2.pdf.
82. Queensland Government. Queensland Statewide Renal Health Services Plan, 2008–17, Part 1 Queensland, Australia 2008 [updated 2008; cited 2013 July 16]. Available from: http://pandora.nla.gov.au/pan/108521/20091015-1137/www.health.qld.gov.au/publications/qh_plans/QS_renal_plan_part1.pdf.
83. Australia and New Zealand Dialysis and Transplant Registry. ANZDATA Registry 2010 Report: Australia and New Zealand Dialysis and Transplant Registry; 2012 [updated 2012; cited 2013 July 16]. Available from: http://www.anzdata.org.au/v1/report_2010.html.
84. Governments CoA. National Healthcare Agreement Australia: Council of Australian Governments; 2011 [updated August 2011; cited 2012 September 1]. Available from: http://www.federalfinancialrelations.gov.au/content/npa/healthcare/national-agreement-superseded-Jul12.pdf.
85. NSW Department of Health. NSW Renal Dialysis Service Plan to 2011 Sydney, Australia 2007 [updated 2007; cited 2013 July 16]. Available from: http://www.aci.health.nsw.gov.au/__data/assets/pdf_file/0007/155059/nswrenalplan_jan2007_final.pdf.
86. Honkanen EO, Rauta VM. What happened in Finland to increase home hemodialysis? Hemodial Int 2008; 12(Suppl 1):S11–5.
87. Helantera I, Haapio M, Koskinen P, Gronhagen-Riska C, Finne P. Employment of patients receiving maintenance dialysis and after kidney transplant: a cross-sectional study from Finland. Am J Kidney Dis 2012; 59(5):700–6.
88. Ashton T, Marshall MR. The organization and financing of dialysis and kidney transplantation services in New Zealand. Int J Health Care Finance Econ 2007; 7(4):233–52.
89. Vanholder R, Davenport A, Hannedouche T, Kooman J, Kribben A, Lameire N, et al. Reimbursement of dialysis: a comparison of seven countries. J Am Soc Nephrol 2012; 23(8):1291–8.
90. Laplante S, Vanovertveld P. A renal policy and financing framework to understand which factors favour home treatments such as peritoneal dialysis. In: Krediet RT, ed. Progress in Peritoneal Dialysis. Rijeka: Intech; 2011:115–32.
91. Just PM, de Charro FT, Tschosik EA, Noe LL, Bhattacharyya SK, Riella MC. Reimbursement and economic factors influencing dialysis modality choice around the world. Nephrol Dial Transplant 2008; 23(7):2365–73.
92. Lameire N, Van BW. Epidemiology of peritoneal dialysis: a story of believers and nonbelievers. Nat Rev Nephrol 2010; 6(2):75–82.
93. Correa-Rotter R. The cost barrier to renal replacement therapy and peritoneal dialysis in the developing world. Perit Dial Int 2001; 21(Suppl 3):S314–7.
94. Lamas Barreiro JM, Alonso SM, Saavedra Alonso JA, Gandara MA. Costs and added value of haemodialysis and peritoneal dialysis outsourcing agreements. Nefrologia 2011; 31(6):656–63.
95. Jha V. Peritoneal dialysis in India: current status and challenges. Perit Dial Int 2008; 28(Suppl 3):S36–41.
96. Teerawattananon Y, Mugford M, Tangcharoensathien V. Economic evaluation of palliative management versus peritoneal dialysis and hemodialysis for end-stage renal disease: evidence for coverage decisions in Thailand. Value Health 2007; 10(1):61–72.
97. Fang W, Qian J, Lin A, Rowaie F, Ni Z, Yao Q, et al. Comparison of peritoneal dialysis practice patterns and outcomes between a Canadian and a Chinese centre. Nephrol Dial Transplant 2008; 23(12):4021–8.
98. Plantinga LC, Fink NE, Finkelstein FO, Powe NR, Jaar BG. Association of peritoneal dialysis clinic size with clinical outcomes. Perit Dial Int 2009; 29(3):285–91.
99. Afolalu B, Troidle L, Osayimwen O, Bhargava J, Kitsen J, Finkelstein FO. Technique failure and center size in a large cohort of peritoneal dialysis patients in a defined geographic area. Perit Dial Int 2009; 29(3):292–6.
100. Thaiyuenwong J, Mahatanan N, Jiravaranun S, Boonyakarn A, Rodpai S, Eiam-Ong S, et al. Nationwide peritoneal dialysis nurse training in Thailand: 3-year experience. J Med Assoc Thai 2011; 94(Suppl 4):S162–6.
101. Pecoits-Filho R, Campos C, Cerdas-Calderon M, Fortes P, Jarpa C, Just P, et al. Policies and health care financing issues for dialysis in Latin America: extracts from the roundtable discussion on the economics of dialysis and chronic kidney disease. Perit Dial Int 2009; 29(Suppl 2):S222–6.
102. Pecoits-Filho R, Abensur H, Cueto-Manzano AM, Dominguez J, Divino Filho JC, Fernandez-Cean J, et al. Overview of peritoneal dialysis in Latin America. Perit Dial Int 2007; 27(3):316–21.
103. Li PK, Chow KM. Peritoneal dialysis-first policy made successful: perspectives and actions. Am J Kidney Dis 2013; 62(5):993–1005.
104. Chaudhary K. Peritoneal dialysis drop-out: causes and prevention strategies. Int J Nephrol 2011; 2011:434-608.
105. Kanjanabuch T, Chancharoenthana W, Katavetin P, Sritippayawan S, Praditpornsilpa K, Ariyapitipan S, et al. The incidence of peritoneal dialysis-related infection in Thailand: a nationwide survey. J Med Assoc Thai 2011; 94(Suppl 4):S7–12.
106. Szeto CC, Chow KM, Kwan BC, Law MC, Chung KY, Leung CB, et al. The impact of social support on the survival of Chinese peritoneal dialysis patients. Perit Dial Int 2008; 28(3):252–8.
107. Zhang AH, Bargman JM, Lok CE, Porter E, Mendez M, Oreopoulos DG, et al. Dialysis modality choices among chronic kidney disease patients: identifying the gaps to support patients on home-based therapies. Int Urol Nephrol 2010; 42(3):759–64.
108. Tungsanga K, Kanjanabuch T, Mahatanan N, Praditpornsilp K, Avihingsanon Y, Eiam-Ong S. The status of, and obstacles to, continuous ambulatory peritoneal dialysis in Thailand. Perit Dial Int 2008; 28(Suppl 3):S53–S8.
109. Marron B, Ortiz A, de Sequera P, Martin-Reyes G, de Arriba G, Lamas JM, et al. Impact of end-stage renal disease care in planned dialysis start and type of renal replacement therapy—a Spanish multicentre experience. Nephrol Dial Transplant 2006; 21(Suppl 2):II51–5.
110. Mehrotra R, Marsh D, Vonesh E, Peters V, Nissenson A. Patient education and access of ESRD patients to renal replacement therapies beyond in-center hemodialysis. Kidney Int 2005; 68(1):378–90.
111. Wuerth DB, Finkelstein SH, Schwetz O, Carey H, Kliger AS, Finkelstein FO. Patients’ descriptions of specific factors leading to modality selection of chronic peritoneal dialysis or hemodialysis. Perit Dial Int 2002; 22(2):184–90.
112. Klang B, Bjorvell H, Clyne N. Predialysis education helps patients choose dialysis modality and increases disease-specific knowledge. J Adv Nurs 1999; 29(4):869–76.
113. Manns BJ, Taub K, Vanderstraeten C, Jones H, Mills C, Visser M, et al. The impact of education on chronic kidney disease patients’ plans to initiate dialysis with self-care dialysis: a randomized trial. Kidney Int 2005; 68(4):1777–83.
114. Walker RC, Marshall MR. Increasing the uptake of peritoneal dialysis in New Zealand: a national survey. J Renal Care 2013; 40(1):40–8.
115. World Health Organization. The world health report: health systems financing: the path to universal coverage. Geneva, Switzerland: WHO Press; 2010. Available from: http://www.who.int/whr/2010/en/index.html.
116. Oliver MJ, Garg AX, Blake PG, Johnson JF, Verrelli M, Zacharias JM, et al. Impact of contraindications, barriers to self-care and support on incident peritoneal dialysis utilization. Nephrol Dial Transplant 2010; 25(8):2737–44.
117. Schatell D, Alt PS. How understanding motivation can improve dialysis practices. Nephrol News Issues 2008; 22(10):32–3, 36.
118. Stack AG, Martin DR. Association of patient autonomy with increased transplantation and survival among new dialysis patients in the United States. Am J Kidney Dis 2005; 45(4):730–42.
119. Ludlow MJ, Lauder LA, Mathew TH, Hawley CM, Fortnum D. Australian consumer perspectives on dialysis: first national census. Nephrology 2012; 17(8):703–9.
120. Van Biesen W, Vanholder RC, Veys N, Dhondt A, Lameire NH. An evaluation of an integrative care approach for end-stage renal disease patients. J Am Soc Nephrol 2000; 11(1):116–25.
121. Komenda P, Sood MM. The economics of home dialysis: acting for the individual while planning responsibly for the population. Adv Chronic Kidney Dis 2009; 16(3):198–204.
122. Burkart J. The future of peritoneal dialysis in the United States: optimizing its use. Clin J Am Soc Nephrol 2009; 4(Suppl 1):S125–31.
123. Chaudhary K, Sangha H, Khanna R. Peritoneal dialysis first: rationale. Clin J Am Soc Nephrol 2011; 6(2):447–56.
124. Gokal R. Peritoneal dialysis in the 21st century: an analysis of current problems and future developments. J Am Soc Nephrol 2002; 13(Suppl 1):S104–16.
125. Jose MD, Johnson DW, Mudge DW, Tranaeus A, Voss D, Walker R, et al. Peritoneal dialysis practice in Australia and New Zealand: a call to action. Nephrology (Carlton) 2011; 16(1):19–29.
126. Ghaffari A, Kalantar-Zadeh K, Lee J, Maddux F, Moran J, Nissenson A. PD First: peritoneal dialysis as the default transition to dialysis therapy. Semin Dialysis 2013; 26(6):706–13.
127. The Commonwealth Fund. International Profiles of Health Care Systems, 2012. Available from: http://www.commonwealthfund.org/~/media/Files/Publications/Fund%20Report/2012/Nov/1645_Squires_intl_profiles_hlt_care_systems_2012.pdf.
128. National Institute for Health and Clinical Excellence. NICE Clinical Guideline 125: Peritoneal dialysis in the treatment of stage 5 chronic kidney disease. In: National Health Services, ed. UK: 2011. Available from: http://guidance.nice.org.uk/CG125/NICEGuidance/pdf/English. Accessed on 10 March 2014.